Last Updated: 04/06/07
U.S. Food and Drug Administration
Website: http://www.fda.gov
Through an agreement with the FDA, a CDP staff member has a joint appointment with NCI and FDA. This person has primary responsibility as a program director managing a portfolio of technology development and proteomics grants in the CDP Diagnostic Biomarkers and Technology Branch. At FDA, the staff person runs a laboratory that is carrying out research on microarray methods (a powerful technology that allows simultaneous measurement of expression levels for up to tens of thousands of genes) for detecting food-borne pathogens. The technology used at FDA is complementary to the technologies being used to detect molecular changes in cancer at NCI. The staff person also serves as a liaison between NCI and FDA on issues related to technology applications.
